Yokohama City University

What Yokohama City University does

Yokohama City University is a public municipal university located in Yokohama, Kanagawa Prefecture, Japan, founded in 1882 and operating with 1,001–5,000 employees. The institution delivers higher education, conducts academic research, and runs Yokohama City University Hospital, which provides clinical services through the Japanese national healthcare system. Its research portfolio spans three notable areas: a pilot study of anime avatar-based online counselling for young adults with depression (pioneered by psychiatrist Francesco Panto), a retrospective clinical study on peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine tumors conducted with University Hospital Basel, and a dyspnea management research project using the AI-powered NEXT Stage EDC platform in collaboration with TXP Medical and Nagasaki University. The university is not a commercial enterprise; it is publicly funded and structured under municipal governance, with no disclosed revenue, ownership stakes, or external investors.

Name

Yokohama City University

Legal name

Yokohama City University

Website

https://yokohama-cu.ac.jp

Company type

Private

Founded year

1882

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Yokohama City University is a public municipal university in Yokohama, Japan, founded in 1882, providing higher education, research, and hospital-based clinical services, with active programs in anime-based mental health therapy, PRRT oncology research, and AI-powered clinical data systems.

Ownership category

akta.pro rank

Product category

Higher Education

NAICS

Diagnostic Imaging Centers (621512), Nursing Care Facilities (Skilled Nursing Facilities) (6231)

SIC

Services-Health Services (8000)

akta.pro primary industry

Therapeutic Radiopharmaceuticals (Radioligand/Targeted Radionuclide Therapy) (HLAIAGAB)

akta.pro secondary industries

Radiation Oncology (HLAKAFAC), Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI), Liver & GI Clinical Research (Trials Centers) (HLAKAEAL), Clinical Research Support (CRC/CTA) (EDAOAJAO)

Keywords

• Higher education
• Medical research
• Clinical research services
• University hospital services
• Mental health research

Headquarters

HQ city

Yokohama

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Distribution channels1 record

Marketing channels4 records

Core offering

Yokohama City University is a public municipal university in Japan that delivers higher education programs, operates a university hospital providing clinical care, and conducts academic and medical research. Notable research activities include a pilot study on anime-based character therapy for young adults with depression, retrospective clinical research on peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine tumors, and collaborative development of an AI-powered Electronic Data Capture (EDC) system for clinical research data.

Product overview

Yokohama City University is a higher education and research institution that does not offer commercial products or services. The university conducts academic research across various fields including medical studies, mental health therapy approaches, and healthcare technology collaborations. Notable research initiatives include anime-based therapy exploration for mental health (conducted by psychiatrist Francesco Panto), a clinical study on peptide receptor radionuclide therapy for metastatic rectal neuroendocrine tumors conducted at Yokohama City University Hospital, and a collaborative research project with Nagasaki University and TXP Medical Co., Ltd. studying dyspnea management using generative AI-powered electronic data capture technology.

Differentiator

Problem solved

Functional benefit

Products and services

• Higher Education Degree Programs
• Yokohama City University Hospital Clinical Services
• Anime-Based Mental Health Therapy Pilot Program
• Peptide Receptor Radionuclide Therapy (PRRT)
• NEXT Stage EDC Research Platform

Quantifiable outcome

• 80% disease control rate in PRRT treatment for metastatic rectal neuroendocrine tumors
• +4 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature2 records

Partnerships

Six partnerships are on record, tiered minor and core.

• Yokohama CityminorGTM or Marketing Partner · 9 March 2026Yokohama City and Yokohama City Tourism Association partnered with STPR Family for a city-wide tourism promotion campaign running from March 9 to 29, 2026, featuring themed decorations, photo spots, digital stamp rally, and live events at K Arena Yokohama.
• Yokohama City Tourism AssociationminorGTM or Marketing Partner · 9 March 2026Yokohama City Tourism Association collaborated with STPR Family on a tourism promotion campaign spanning multiple Yokohama landmarks including Minato Mirai, Yokohama Red Brick Warehouse, and Yokohama Chinatown.
• STPR Co., Ltd. (STPR Family)minorGTM or Marketing Partner · 9 March 2026STPR Family, a 2.5-dimensional idol group managed by STPR Co., Ltd., partnered with Yokohama City and the Tourism Association for a city-wide tourism promotion campaign featuring themed ticket gates, photo spots, merchandise pop-ups, and digital stamp rally.
• Nagasaki UniversitycoreStrategic or Co-development Partner · 1 March 2026Nagasaki University and Yokohama City University are collaborating with TXP Medical Co., Ltd. starting March 2026 on a research project studying dyspnea management in primary care, utilizing the AI-powered NEXT Stage EDC system for extracting unstructured medical record data.
• TXP Medical Co., Ltd.coreTechnology or Integration · 1 March 2026TXP Medical is providing the AI-powered NEXT Stage EDC platform that leverages generative AI to extract and analyze unstructured medical record data, enabling automation of data processing tasks previously requiring manual work by researchers.
• University Hospital BaselcoreStrategic or Co-development Partner · 1 April 2024University Hospital Basel collaborated with Yokohama City University Hospital on a retrospective study analyzing 20 Japanese patients with metastatic rectal neuroendocrine tumors treated with peptide receptor radionuclide therapy between April 2015 and May 2023.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• University of Tokyo: Japan's flagship national research university with a major medical school and university hospital. Most directly comparable to YCU as a public research institution conducting advanced medical research and operating clinical services.
• Kyoto University: Top-tier Japanese national university with strong medical and life sciences research programs and an affiliated hospital. Comparable to YCU in research scale, clinical operations, and public-mandate structure.
• Osaka University: Major Japanese national research university with a medical school and university hospital conducting oncology, radiopharmaceutical, and clinical research. Closely aligned with YCU's profile of running hospital-based translational research.
• Keio University: One of Japan's leading private universities with a major medical school and university hospital. Comparable to YCU for clinical research activity, hospital operations, and translational medicine partnerships.
• Nagoya University: Major Japanese national research university with a medical school and university hospital. Relevant peer given its parallel partnership with YCU on the TXP Medical NEXT Stage EDC dyspnea management research project starting March 2026.
• National Cancer Center Japan: Japan's primary national institution dedicated to cancer research and treatment. Comparable to YCU for radiopharmaceutical therapy research, oncology trials, and specialized clinical service delivery.
• Tokyo Medical and Dental University: Japan's leading medical and dental research university. Closely comparable to YCU for medical research focus, hospital operations, and clinical trial activity.
• Tohoku University: Major Japanese national research university with a medical school and university hospital conducting advanced clinical and translational research. Comparable institutional scale and mandate to YCU.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/ycu_koho
• Facebookfacebook.com/yokohamacityuniv

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Yokohama City University